138 results
8-K
EX-99.1
CSBR
Champions Oncology, Inc.
11 Sep 24
Champions Oncology Reports Quarterly Revenue of $14.1 Million
4:34pm
and other cost reduction initiatives.
Research and development expense for the three-months ended July 31, 2024 was $1.5 million, a decrease of $1.3 … revenue
Cost of oncology services
Research and development
Sales and marketing
General and administrative
Income (loss) from operations
Other income
8-K
EX-99.1
CSBR
Champions Oncology, Inc.
18 Jul 24
Champions Oncology Reports Quarterly Revenue of $14.0 Million
4:13pm
resulted from the improved revenue conversion while maintaining a generally stable cost structure.
Research and development expense was $2.0 million … , the variable cost component of cost of sales did not decline meaningfully despite the lower study volume.
Research and development expense was $9.5 million
8-K
EX-99.1
qft0bn6e83i4u3a9o
12 Mar 24
Champions Oncology Reports Quarterly Revenue of $12.0 Million
4:31pm
8-K
EX-99.1
1jes2s6p
12 Dec 23
Champions Oncology Reports Quarterly Revenue of $11.6 Million
4:14pm
8-K
EX-99.1
kjvu mh3jje
13 Sep 23
Champions Oncology Reports Quarterly Revenue of $12.6 Million
4:00pm
8-K
EX-99.1
eyl5 x8o3
24 Jul 23
Champions Oncology Reports Quarterly Revenue of $13.1 Million
4:04pm
8-K
EX-99.1
5y6mmx 4t1
13 Dec 22
Champions Oncology Reports Record Quarterly Revenue of $14.3 Million
4:01pm
8-K
EX-99.1
wvki4mzs
8 Sep 22
Champions Oncology Reports Record Quarterly Revenue of $13.7 Million
3:59pm
8-K
EX-99.1
qwy ndkn84irdo
21 Jul 22
Champions Oncology Reports Quarterly Revenue of $12.9 Million
3:59pm
8-K
EX-99.1
bg94e020pucz c4i
15 Mar 22
Champions Oncology Reports Record Quarterly Revenue of $13.2 Million
4:31pm